Benefits
PMS symptom relief
A systematic review and meta-analysis of randomized trials found chasteberry associated with greater improvement in premenstrual symptoms than placebo across physical (bloating, breast tenderness, headache), behavioral (irritability, mood swings), and psychological (anxiety, low mood) domains, with responder rates around 50-80% in some trials. The review's authors cautioned that high risk of bias, heterogeneity in extract types/doses, and possible publication bias make the true effect size uncertain.
Cyclical mastalgia relief
Chasteberry is one of the better-studied botanicals for cyclical breast tenderness (mastalgia). Randomized trials have reported reductions in breast-tenderness scores with chasteberry extracts. A double-blind, placebo-controlled trial in 97 women found breast pain fell faster with chasteberry than with placebo over three cycles.
Prolactin normalization and hormone balance
The dopamine agonist mechanism of chasteberry reduces elevated prolactin levels (latent hyperprolactinemia) — a key driver of luteal phase insufficiency, PMS symptoms, and irregular menstrual cycles. Research suggests that by supporting normal prolactin levels, chasteberry may help support luteal-phase progesterone and menstrual-cycle regularity, though much of the progesterone data comes from mechanistic and animal studies rather than human outcome trials.
Irregular menstrual cycle regulation
Chasteberry has traditionally been used to support more regular menstrual cycles, and some studies report improved cycle regularity over roughly 3 to 6 cycles. Rigorous controlled trials for irregular-cycle conditions such as oligomenorrhea or amenorrhea are limited and are not cited on this page.
Mechanism of action
Dopamine D2 receptor agonism and prolactin suppression
Chasteberry diterpenes (particularly rotundifuran) bind dopamine D2 receptors on pituitary lactotroph cells, inhibiting prolactin secretion. Since prolactin excess drives luteal phase insufficiency, breast pain, and many PMS symptoms, this dopaminergic mechanism is one proposed way chasteberry may support premenstrual comfort.
Mu-opioid receptor partial agonism
In laboratory studies, casticin and other chasteberry flavonoids show partial agonist activity at mu-opioid receptors — a preclinical finding that has been proposed, but not confirmed in humans, to contribute to pain and mood effects alongside the dopaminergic mechanism. This opioid pathway modulation may explain PMS-associated pain relief beyond prolactin reduction.
Progesterone receptor expression upregulation
By reducing prolactin and improving luteal phase function, chasteberry has been proposed to influence progesterone receptor expression and luteal-phase progesterone signaling in preclinical models; whether this meaningfully alters estrogen-progesterone balance in women remains unproven.
Clinical trials
Evidence review and pooled analysis of randomized, double-blind, placebo-controlled trials examining Vitex agnus-castus extract for premenstrual syndrome. (Verkaik et al. 2017, Am J Obstet Gynecol, PMID 28237870)
Pooled across multiple trials.
Vitex agnus-castus significantly more effective than placebo for overall PMS symptom reduction. Notable for breast tenderness, mood symptoms, and irritability. Effect sizes meaningful for moderate PMS. Note: heterogeneity in extract types and doses limits precise effect estimation; standardized extracts (Ze 440, Premular) have the strongest evidence.
Double-blind, placebo-controlled trial of Vitex agnus-castus extract versus placebo in women with cyclical mastalgia. (Halaska et al. 1998, Ceska Gynekol, PMID 9818496)
97 women with cyclical mastalgia, treated for 3 menstrual cycles (Vitex n=48, placebo n=49).
Breast pain measured on a visual analogue scale diminished faster with Vitex agnus-castus (n=48) than with placebo (n=49) over three menstrual cycles, and tolerability was satisfactory. This is a single modest-sized trial: it supports relief of cyclical breast pain but does not by itself establish the size of the effect.